Evidence map›Paper›PMID 29362406›Full record

ArticleEmerging microbes & infections2018

Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016.

Jiayu Wang, Zheng Teng, Xiaoqing Cui, Chongshan Li, Hao Pan, Yaxu Zheng, Shenghua Mao, Yuying Yang, Limeng Wu, Xiaokui Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Experimental animal models for development of human enterovirus vaccine.Clinical and experimental vaccine research · 2023
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jiayu WangDepartment of Microbiology and Immunology, Institutes of Medical Science, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zheng TengMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Xiaoqing CuiMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Chongshan LiExpanded Program on Immunization Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Hao PanMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Yaxu ZhengMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Shenghua MaoMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Yuying YangExpanded Program on Immunization Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Limeng WuMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China.
Xiaokui GuoDepartment of Microbiology and Immunology, Institutes of Medical Science, Shanghai Jiao Tong University School of Medicine, Shanghai, China. xkguo@shsmu.edu.cn.
Xi ZhangMicrobiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, China. zhangxi@scdc.sh.cn.
Yongzhang ZhuDepartment of Microbiology and Immunology, Institutes of Medical Science, Shanghai Jiao Tong University School of Medicine, Shanghai, China. yzhzhu@hotmail.com.
Shanghai Municipal Center For Disease Control Prevention · CNFudan University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aside from enterovirus 71 (EV71) and coxsackie virus A16 (CV-A16), viruses that are known to cause hand-foot-and-mouth disease (HFMD), epidemiological profiles of other enteroviruses that induce HFMD are limited. We collected 9949 laboratory surveillance HFMD cases and 1230 serum samples from infants and children in Shanghai from 2012-2016. Since 2013, CV-A6 has displaced EV71 and CV-A16 to become the predominant serotype. Interestingly, novel epidemiological patterns in EV71 and CV-A16 infections were observed, with one large peak in both 2012 and 2014, followed by two smaller peaks in the respective following years (2013 and 2015). Through sequencing, we found that C4a, B1b, D-Cluster-1 and B constituted the major subgenotypes of EV71, CV-A16, CV-A6 and CV-A10, respectively. Among healthy individuals, 50.49% and 54.23% had positive neutralising antibodies (NtAbs) against EV71 and CV-A16, respectively, indicating that EV71 and CV-A16 silent infections were common. These populations may be an important potential source of infection. The overall seropositive rate of EV71 NtAbs showed a fluctuating, markedly downward trend, indicating the potential risk of a future EV71 epidemic. High CV-A16 NtAb seroprevalence corroborated a documented CV-A16 'silent' epidemic. Children aged 1-5 years had the lowest EV71 NtAb seropositive rate, whereas those aged 1-2 years exhibited the lowest CV-A16 NtAb seropositive rate. This is the first comprehensive investigation of the epidemiology and aetiology, as well as the seroprevalence, of HFMD in Shanghai between 2012 and 2016. This study provides the latest insights into developing a more efficient HMFD vaccination programme.

Indexed as

Seroepidemiologic StudiesAdolescentAnimalsAntibodies, ViralChildChild, PreschoolChinaEnterovirus A, HumanEpidemicsEpidemiological MonitoringFemaleHand, Foot and Mouth DiseaseHumansImmunologic SurveillanceInfantInfant, NewbornAntibodies, Viral

Identifiers

PMID29362406
PMCPMC5837173
OpenAlexW2806768671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.